PARFRESPE
Aventis Pharma S.a.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78315679 |
| Registration Number | 3102944 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Cancellation Code | 2 |
| Domestic Representative | Margaret H. Bitler |
| Attorney Name | Margaret H. Bitler |
| Attorney Docket Number | A4412-US |
| Law Office Assigned | L20 |
| Employee Name | FERRAIUOLO, DOMINIC J |
Timeline
| 2003-10-20 | Application Filed |
| 2006-03-21 | Published for Opposition |
| 2006-06-13 | Location: PUBLICATION AND ISSUE SECTION |
| 2006-06-13 | Trademark Registered |
| 2013-01-18 | Cancelled |
| 2013-01-18 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  AVENTIS PHARMA S.A. |
| Address | 20 avenue Raymond Aron Antony FR 92160 |
| Legal Entity Type | Corporation |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical preparations, namely anti-infective preparations, preparations for the treatment of respiratory diseases, of cardiovascular diseases, of diabetes, of arthritis, of osteoporosis, of central nervous system, of cancer |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2003-11-03 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2004-03-26 | 2 DOCK D:Assigned to Examiner |
| LETTER OF SUSPENSION E-MAILED | 2004-03-29 | 3 GNSL F:First Action |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2004-11-18 | 4 RCCK S: |
| PAPER RECEIVED | 2005-02-23 | 5 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2005-02-23 | 6 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2005-03-29 | 7 ACEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2005-03-31 | 8 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2005-04-01 | 9 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2005-04-05 | 10 PREV O:Outgoing Correspondence |
| PETITION TO DIRECTOR RECEIVED | 2005-02-23 | 11 PCRC I:Incoming Correspondence |
| PETITION TO DIRECTOR DISMISSED | 2005-05-10 | 12 PC.D T:TTAB Proceeding |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2005-08-10 | 13 TCCA I:Incoming Correspondence |
| NOTICE OF PUBLICATION | 2006-03-01 | 14 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2006-03-21 | 15 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2006-06-13 | 16 R.PR A:Allowance for Publication |
| CANCELLED SEC. 8 (6-YR) | 2013-01-18 | 17 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 PARFRESPE 85622770 4271453 Dead/Cancelled |
Aventis Pharma S.A. 2012-05-11 |
 PARFRESPE 78315679 3102944 Dead/Cancelled |
AVENTIS PHARMA S.A. 2003-10-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 